Carbamazepine ER
NDC 72516-021, Carbamazepine, tablet, extended release, from Oryza Pharmaceuticals Inc..
- Product NDC
- 72516-021
- Status
- Listed
- Labeler
- Oryza Pharmaceuticals Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212948
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72516-021 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARBAMAZEPINE400 mg/1
Pharmacologic classes
Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72516-021-01 | 72516002101 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-021-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/34b375d0-68b0-4bd5-8ac9-be043b57e91cNADAC price for package 72516002101
GET /v1/drugs/nadac/72516002101
Use it
Look up 72516-021 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72516-021 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72516-021. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.